GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:01200327 | Lung | IAC | regulation of plasma membrane bounded cell projection assembly | 39/2061 | 186/18723 | 5.41e-05 | 1.21e-03 | 39 |
GO:00604916 | Lung | IAC | regulation of cell projection assembly | 39/2061 | 188/18723 | 6.92e-05 | 1.47e-03 | 39 |
GO:00313466 | Lung | IAC | positive regulation of cell projection organization | 63/2061 | 353/18723 | 7.37e-05 | 1.55e-03 | 63 |
GO:00512357 | Lung | IAC | maintenance of location | 58/2061 | 327/18723 | 1.66e-04 | 2.96e-03 | 58 |
GO:19021152 | Lung | IAC | regulation of organelle assembly | 37/2061 | 186/18723 | 2.55e-04 | 4.26e-03 | 37 |
GO:00488633 | Lung | IAC | stem cell differentiation | 38/2061 | 206/18723 | 9.79e-04 | 1.18e-02 | 38 |
GO:00516518 | Lung | IAC | maintenance of location in cell | 39/2061 | 214/18723 | 1.07e-03 | 1.26e-02 | 39 |
GO:0060271 | Lung | IAC | cilium assembly | 55/2061 | 337/18723 | 1.84e-03 | 1.88e-02 | 55 |
GO:0044782 | Lung | IAC | cilium organization | 58/2061 | 368/18723 | 3.15e-03 | 2.75e-02 | 58 |
GO:00325075 | Lung | IAC | maintenance of protein location in cell | 15/2061 | 65/18723 | 4.02e-03 | 3.30e-02 | 15 |
GO:00604852 | Lung | IAC | mesenchyme development | 47/2061 | 291/18723 | 4.61e-03 | 3.64e-02 | 47 |
GO:00451858 | Lung | IAC | maintenance of protein location | 19/2061 | 94/18723 | 6.26e-03 | 4.48e-02 | 19 |
GO:00487623 | Lung | IAC | mesenchymal cell differentiation | 39/2061 | 236/18723 | 6.33e-03 | 4.51e-02 | 39 |
GO:012003213 | Lung | AIS | regulation of plasma membrane bounded cell projection assembly | 37/1849 | 186/18723 | 2.67e-05 | 8.60e-04 | 37 |
GO:006049113 | Lung | AIS | regulation of cell projection assembly | 37/1849 | 188/18723 | 3.41e-05 | 1.05e-03 | 37 |
GO:004886312 | Lung | AIS | stem cell differentiation | 39/1849 | 206/18723 | 5.25e-05 | 1.51e-03 | 39 |
GO:005123512 | Lung | AIS | maintenance of location | 55/1849 | 327/18723 | 5.93e-05 | 1.65e-03 | 55 |
GO:005165113 | Lung | AIS | maintenance of location in cell | 39/1849 | 214/18723 | 1.23e-04 | 2.81e-03 | 39 |
GO:003134612 | Lung | AIS | positive regulation of cell projection organization | 57/1849 | 353/18723 | 1.38e-04 | 3.05e-03 | 57 |
GO:190211511 | Lung | AIS | regulation of organelle assembly | 34/1849 | 186/18723 | 3.06e-04 | 5.62e-03 | 34 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TAPT1 | SNV | Missense_Mutation | | c.349T>G | p.Phe117Val | p.F117V | Q6NXT6 | protein_coding | tolerated(0.06) | benign(0.255) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | novel | c.957A>G | p.Ile319Met | p.I319M | Q6NXT6 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | novel | c.1577N>G | p.Phe526Cys | p.F526C | Q6NXT6 | protein_coding | tolerated(0.09) | possibly_damaging(0.635) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | novel | c.898N>G | p.Phe300Val | p.F300V | Q6NXT6 | protein_coding | deleterious(0) | possibly_damaging(0.48) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | novel | c.1586C>T | p.Thr529Ile | p.T529I | Q6NXT6 | protein_coding | tolerated(0.07) | probably_damaging(0.991) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | novel | c.1322C>T | p.Ser441Phe | p.S441F | Q6NXT6 | protein_coding | deleterious(0) | possibly_damaging(0.837) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | | c.1320N>G | p.Ile440Met | p.I440M | Q6NXT6 | protein_coding | tolerated(0.14) | possibly_damaging(0.776) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
TAPT1 | deletion | Frame_Shift_Del | novel | c.371delN | p.Leu124CysfsTer9 | p.L124Cfs*9 | Q6NXT6 | protein_coding | | | TCGA-AX-A3FS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | | c.1508N>A | p.Ile503Asn | p.I503N | Q6NXT6 | protein_coding | tolerated(0.06) | benign(0.17) | TCGA-BW-A5NQ-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
TAPT1 | SNV | Missense_Mutation | novel | c.1339N>T | p.Ser447Cys | p.S447C | Q6NXT6 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-DD-AAEI-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |